Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$140,000.00

Regulation and function of human tumor-exosome induced myeloid-derived suppressor cells in metastasis and infection.

FY 2017-18

Summary
Cancer is the leading cause of death in Canada, resulting in 80,000 deaths per year. In addition to the type of cancer, the main predictor of cancer outcome is the presence of metastasis. Metastasis is the presence of tumor cells at distant sites in the body. To this day, scientists do not understand exactly how metastasis occurs and medical doctors have no specific drugs to prevent it. Our current models suggest that tumors release very small packages called 'exosomes' into the bloodstream that act like 'messages in a bottle' to establish new 'homes' at distant sites in the body. Exosomes also contain instructions that increase cells that suppress the immune system. This allows tumor cells to move around the body unnoticed. One such immune cell is the 'myeloid-derived suppressor cell' or MDSC. We understand how these events might happen largely from animal models and 2-dimensional human cell culture but these have limitations when trying to develop new therapies for humans. Further affecting outcomes in cancer patients are infections, which contribute directly or indirectly to >50% of cancer-related deaths. Whether the underlying changes to the immune system that allow metastasis to occur also contribute to the >10-600-fold increased risk of infection in cancer patients is unknown. It is possible that the increased risk for infection and death in cancer patients is an underlying increase in immune suppressive MDSCs. We will determine how cancer exosomes and the immune suppressing cells they generate provide a crucial link between infection and metastasis in oncology patients. We will be using computer chip printing technology to engineer 3-dimensional human tissues. We will use these human 3D tissue models to decipher how cancer exosomes and immune suppressive MDSCs increase metastasis and infection. This approach will allow us to develop new therapies, in a human system, that target common pathways to prevent both metastasis and infection in cancer patients.
Program
CIHR Fellowship
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
376828
Name
Gillrie Mark R
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Regulation and function of human tumor-exosome induced myeloid-derived suppressor cells in metastasis and infection.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
3d Tissue Engineering; Cancer; Infection; Metastasis; Microfluidics; Myeloid-Derived Suppressor Cells; Tumour Exosomes; Tumour Microenvironment
Abstract
Cancer is the leading cause of death in Canada, resulting in 80,000 deaths per year. In addition to the type of cancer, the main predictor of cancer outcome is the presence of metastasis. Metastasis is the presence of tumor cells at distant sites in the body. To this day, scientists do not understand exactly how metastasis occurs and medical doctors have no specific drugs to prevent it. Our current models suggest that tumors release very small packages called 'exosomes' into the bloodstream that act like 'messages in a bottle' to establish new 'homes' at distant sites in the body. Exosomes also contain instructions that increase cells that suppress the immune system. This allows tumor cells to move around the body unnoticed. One such immune cell is the 'myeloid-derived suppressor cell' or MDSC. We understand how these events might happen largely from animal models and 2-dimensional human cell culture but these have limitations when trying to develop new therapies for humans. Further affecting outcomes in cancer patients are infections, which contribute directly or indirectly to >50% of cancer-related deaths. Whether the underlying changes to the immune system that allow metastasis to occur also contribute to the >10-600-fold increased risk of infection in cancer patients is unknown. It is possible that the increased risk for infection and death in cancer patients is an underlying increase in immune suppressive MDSCs. We will determine how cancer exosomes and the immune suppressing cells they generate provide a crucial link between infection and metastasis in oncology patients. We will be using computer chip printing technology to engineer 3-dimensional human tissues. We will use these human 3D tissue models to decipher how cancer exosomes and immune suppressive MDSCs increase metastasis and infection. This approach will allow us to develop new therapies, in a human system, that target common pathways to prevent both metastasis and infection in cancer patients.
Competitiondate
201711
Approvedterm2
2 yrs 4 mths
Pinamesdelim
Gillrie, Mark R
Approvedterm
2 ans 4 mois
Cihrcontribution2
~ $140,000~ $0~